Lin Weng
Impact in
- Biomaterials top 10%
- Electrospun Nanofibers in Biomedical Applications
- Nephrology top 10%
- Parathyroid Disorders and Treatments
Papers in
-
- Mitochondrial Function and Pathology 2
- Signaling Pathways in Disease 2
- Connective Tissue Growth Factor Research 2
-
- Cardiac electrophysiology and arrhythmias 3
- Co-authors
- Franklin D. Shuler (3 shared papers)Sunil Kumar Boda (3 shared papers)Jingwei Xie (3 shared papers)Matthew J. Teusink (3 shared papers)Xiaoran Li (1 shared paper)Jingjing Ye (9 shared papers)Ming Zheng (9 shared papers)Chunling Xu (7 shared papers)
- Journals
- Cell Death and Disease (3 papers)Advanced Healthcare Materials (2 papers)Circulation Research (2 papers)Biochemical and Biophysical Research Communications (1 paper)Hypertension (1 paper)
- Partner nations
- ChinaUnited StatesRomania
In The Last Decade
Lin Weng
22 papers receiving 722 citations
Peers
Comparison fields: 5 of 92
- Biomaterials 125
- Nephrology 55
- Oral Surgery 33
- Complementary and Manual Therapy 9
- Aquatic Science 33
Countries citing papers authored by Lin Weng
This map shows the geographic impact of Lin Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Weng more than expected).
Fields of papers citing papers by Lin Weng
This network shows the impact of papers produced by Lin Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Weng. The network helps show where Lin Weng may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Weng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 148 | |
| 2 | 2018 | 99 | |
| 3 | 2001 | 90 | |
| 4 | 2022 | 83 | |
| 5 | 2023 | 52 | |
| 6 | Low molecular weight fucoidan ameliorates diabetic nephropathy via inhibiting epithelial-mesenchymal transition and fibrotic processes. | 2015 | 38 |
| 7 | 2015 | 36 | |
| 8 | 2019 | 36 | |
| 9 | 2022 | 30 | |
| 10 | 2016 | 26 | |
| 11 | 2020 | 18 | |
| 12 | 2022 | 17 | |
| 13 | 2018 | 15 | |
| 14 | 2021 | 14 | |
| 15 | 2018 | 12 | |
| 16 | 2021 | 4 | |
| 17 | 2023 | 3 | |
| 18 | 2025 | 3 | |
| 19 | 2020 | 1 | |
| 20 | 2000 | 1 |
About Lin Weng
Lin Weng is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Cancer Research, Biomedical Engineering and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 728 indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (3 papers), Autophagy in Disease and Therapy (3 papers), Bone Tissue Engineering Materials (3 papers), Corneal Surgery and Treatments (2 papers), Electrospun Nanofibers in Biomedical Applications (2 papers), Mitochondrial Function and Pathology (2 papers), Signaling Pathways in Disease (2 papers) and Connective Tissue Growth Factor Research (2 papers). The work is most often cited by research in Biomaterials (125 citations), Nephrology (55 citations), Oral Surgery (33 citations), Complementary and Manual Therapy (9 citations) and Aquatic Science (33 citations). Lin Weng has collaborated with scholars based in China, United States and Romania. Frequent co-authors include Franklin D. Shuler, Sunil Kumar Boda, Jingwei Xie, Matthew J. Teusink, Xiaoran Li, Jingjing Ye, Ming Zheng, Chunling Xu, Matthias Meier and G. Goeckenjan. Their work appears in journals such as Cell Death and Disease, Advanced Healthcare Materials, Circulation Research, Biochemical and Biophysical Research Communications and Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.